Midday Report: Alx Oncology (ALXO) Gains on June 23

Equities Staff  |

Alx Oncology Holdings Inc (NASDAQ: ALXO) shares have risen 6.85%, or $0.465 per share, as on 11:44:00 est today. After Opening the Day at $6.85, 53,712 shares of Alx Oncology have been traded today and the stock has moved between $7.28 and $6.85.  

Already the company has moved YTD 68.40%.

Alx Oncology is set to release earnings on 2022-08-09.

For technical charts, analysis, and more on Alx Oncology visit the company profile.

About Alx Oncology Holdings Inc

ALX Oncology Holdings Inc. operates as a clinical stage immuno-oncology company. The Company focuses on helping patients fight cancer by developing therapies that bridge the innate and adaptive immune system. ALX Oncology Holdings serves patients in the State of California.

To get more information on Alx Oncology Holdings Inc and to follow the company's latest updates, you can visit the company's profile page here: Alx Oncology Holdings Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?

Market Movers

Sponsored Financial Content